2021
DOI: 10.1007/s12020-021-02856-1
|View full text |Cite
|
Sign up to set email alerts
|

Radiomics analysis improves 18FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules

Abstract: Purpose As ~25% of cytologically indeterminate thyroid nodules harbour malignancy, diagnostic lobectomy is still performed in many cases. 18FDG PET/CT rules out malignancy in visually negative nodules; however, none of the currently available interpretation criteria differentiates malignant from benign 18FDG-avid nodules. We evaluated the ability of PET metrics and radiomics features (RFs) to predict final diagnosis of 18FDG-avid cytologically indeterminate thyroid nodules. … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
32
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 19 publications
(32 citation statements)
references
References 25 publications
0
32
0
Order By: Relevance
“…Nodules with Hürthle cell cytology should be excluded from visual analysis with [ 18 F]FDG-PET/CT. Any benefits of quantitative [ 18 F]FDG-PET/CT assessment methods, such as SUV-derived analysis, texture analysis, and radiomics, have shown potential in indeterminate thyroid nodules and [ 18 F]FDG-positive thyroid incidentaloma, although the current evidence is limited and further studies are required [22][23][24]. Other diagnostics, such as molecular analysis for specific driver mutations, mitochondrial DNA mutations, and copy number variations, should be considered for Hürthle cell nodules [25][26][27].…”
Section: Discussionmentioning
confidence: 99%
“…Nodules with Hürthle cell cytology should be excluded from visual analysis with [ 18 F]FDG-PET/CT. Any benefits of quantitative [ 18 F]FDG-PET/CT assessment methods, such as SUV-derived analysis, texture analysis, and radiomics, have shown potential in indeterminate thyroid nodules and [ 18 F]FDG-positive thyroid incidentaloma, although the current evidence is limited and further studies are required [22][23][24]. Other diagnostics, such as molecular analysis for specific driver mutations, mitochondrial DNA mutations, and copy number variations, should be considered for Hürthle cell nodules [25][26][27].…”
Section: Discussionmentioning
confidence: 99%
“…Aksu et al [ 28 ] investigated six conventional parameters in their study, excluding MTV, but chose to include only SUV max values in their predictive model. Giovanella et al [ 29 ] estimated the values of SUV max , SUV mean , MTV, and TLG, but only SUV max and TLG retained statistical significance as malignancy predictors. However, these studies did not focus on the usage of volumetric parameters as predictors for malignancy in FDG-avid thyroid incidentalomas, but on their integration in further predictive models, alongside histogram-based or texture radiomics features.…”
Section: Resultsmentioning
confidence: 99%
“…To the best of our knowledge, our study is the second to report PET/CT radiomics in indeterminate thyroid nodules. Giovanella et al recently published the first study in 78 Bethesda III/IV patients, demonstrating a 96% NPV and 58% PPV for a multiparametric model including the cytological classification and two radiomic features [19]. PPV improved to 79% if 13 patients with a histopathological Hürthle cell adenoma were excluded (cytology not reported).…”
Section: Discussionmentioning
confidence: 99%
“…When incorporated in the proposed multiparametric model, however, clinical application of radiomics seems feasible. Future studies are required to validate their results [19].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation